INDEMNIFICATION AGREEMENTIndemnification Agreement • November 18th, 2020 • Myos Rens Technology Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 18th, 2020 Company Industry JurisdictionThis Indemnification Agreement (this “Agreement”) is dated as of [●] and is between MedAvail Holdings, Inc., a Delaware corporation (the “Company”), and [●] (“Indemnitee”).
COMMON STOCK PURCHASE WARRANT MEDAVAIL HOLDINGS, INC.Common Stock Purchase Warrant • November 18th, 2020 • Myos Rens Technology Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 18th, 2020 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 18, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from MedAvail Holdings, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
WARRANT TO PURCHASE SHARES OF COMMON STOCK of MEDAVAIL, INC. Dated as of [●] Void after the date specified in Section 8Warrant Agreement • November 18th, 2020 • Myos Rens Technology Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 18th, 2020 Company Industry JurisdictionTHIS CERTIFIES THAT, for value received, [________________] or its registered assigns (the “Holder”), is entitled, subject to the provisions and upon the terms and conditions set forth herein, to purchase from MedAvail, Inc., a Delaware corporation (the “Company”), shares of the Shares (as defined below), in the amounts, at such times and at the price per share set forth in Section 1. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein. This Warrant is issued in connection pursuant to the terms of the [●] (the “Agreement”) by and among the Company, the original Holder hereof, and certain of the Investors (as defined therein) by and among the Company and the Warrant Holders (as defined therein). This Warrant is one of a series of warrants which may be issued pursuant to the Agreement (collectively, the “Warrants”).